Johns Hopkins researchers have discovered that valproic acid, a widely prescribed drug for treating epilepsy, has the additional benefits of reducing fat accumulation in the liver and lowering blood sugar levels in the blood ...
Jan 29, 2014
0
0
Elevated levels of an amino acid, tyrosine, alter development and longevity in animals and may contribute to the development of diabetes in people, new research from the UT Health Science Center at San Antonio indicates. ...
Dec 19, 2013
0
0
Yes, our prehistoric ancestors had to fend off saber-toothed cats and gigantic hyenas. But did they ever have to take an organic chemistry final or host the in-laws for the holidays? Now that's stress.
Dec 9, 2013
3
0
Eating sushi can increase risk of cardiovascular disease. A recent study showed that tuna sashimi contains the highest levels of methylmercury in fish-sushi, based on samples taken from across the USA.
Nov 25, 2013
1
0
(HealthDay)—Mercury levels in American women of childbearing age have dropped about one-third over a decade, a new federal study shows.
Nov 21, 2013
0
0
Some vegetable oils that claim to be healthy may actually increase the risk of heart disease, and Health Canada should reconsider cholesterol-lowering claims on food labelling, states an analysis in CMAJ (Canadian Medical ...
Nov 11, 2013
0
0
Three new studies suggest that controlling dietary acid intake could help improve kidney health. Results of these studies will be presented at ASN Kidney Week 2013 November 5-10 at the Georgia World Congress Center in Atlanta, ...
Nov 9, 2013
0
0
The risks of developing kidney failure and a calcium deficiency from the popular osteoporosis drug zoledronic acid are extremely rare, according to researchers at Loyola University Health System (LUHS). These findings were ...
Oct 31, 2013
0
0
Distal renal tubular acidosis (dRTA) develops in response to the loss of acid secretion by α-intercalated cells in the kidney. The inability to remove acid from the body results in low blood potassium levels (hypokalemia), ...
Sep 24, 2013
0
0
A drug that appears to target specific intestinal bacteria in the guts of mice may create a chain reaction that could eventually lead to new treatments for obesity and diabetes in humans, according to a team of researchers.
Sep 24, 2013
0
0
